FDA Adverse Event Malfunction Summary report: N

PULSE GEN MODEL 102R

MDR report key: 2955615 · Received February 11, 2013

Report

Report Number
1644487-2013-00364
Event Type
Malfunction
Date Received
February 11, 2013
Date of Event
October 24, 2004
Report Date
January 14, 2013
Manufacturer
CYBERONICS INC
Product Code
LYJ
PMA / PMN Number
P970003
Removal / Correction Number
NA
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
TX, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

DEVICE FAILURE OCCURRED, BUT DID NOT CAUSE OR CONTRIBUTE TO A DEATH OR SERIOUS INJURY. REVIEW OF MANUFACTURING RECORDS CONFIRMED THERE WERE NO UNRESOLVED NON CONFORMANCES FOUND WITH THE GENERATOR PRIOR TO DISTRIBUTION.

Description of Event or Problem · 1

IT WAS INITIALLY REPORTED THAT THE PATIENT HAS A GENERATOR REPLACEMENT. THE GENERATOR WAS RETURNED TO THE MANUFACTURER FOR EVALUATION AND PRODUCT ANALYSIS WAS COMPLETED. THE SUPPLY CURRENT TESTS DID NOT MEET FUNCTIONAL SPECIFICATIONS. THESE MEASUREMENTS DEMONSTRATE AN INCREASED CURRENT CONSUMPTION FOR THE DEVICE, POTENTIALLY CONTRIBUTING TO A PREMATURE END OF LIFE CONDITION. A BATTERY LIFE ESTIMATION RESULTED IN 2.22 YEARS REMAINING BEFORE THE NEOS FLAG WOULD BE SET. HOWEVER, AN INCOMPLETE PROGRAMMING HISTORY INDICATES THE ESTIMATION DOES NOT USE ALL THE DATA REQUIRED TO MAKE AN ACCURATE ESTIMATION. THE INCREASED CURRENT CONSUMPTION WAS ISOLATED TO A LEAKY CAPACITOR (C6). WITH THE CAPACITOR SUBSTITUTION FOR C6, THE PULSE GENERATOR MODULE PERFORMED ACCORDING TO FUNCTIONAL SPECIFICATIONS. THE MOST PROBABLE ROOT CAUSE FOR THE PREMATURE END OF LIFE CONDITION WAS IDENTIFIED TO BE A LEAKY CAPACITOR (C6). CAUSE FOR THE CAPACITORS (C6) INCREASE IN LEAKAGE COULD NOT BE DETERMINED. REVIEW OF MANUFACTURING RECORDS CONFIRMED THERE WERE NO UNRESOLVED NON CONFORMANCES FOUND WITH THE GENERATOR PRIOR TO DISTRIBUTION.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
59920 PULSE GEN MODEL 102R GENERATOR LYJ CYBERONICS INC 102R 011406

Patients

Seq Age Sex Outcome Treatment
1 16 YR